Silo Pharma Launches $2.1 Million Registered Direct Offering; Shares Fall Pre-Bell

MT Newswires Live07-19

Silo Pharma (SILO) said Friday it has agreed to sell 763,638 common shares at a price of $2.75 per share in a registered direct offering.

The company is also issuing warrants to purchase up to 763,638 common shares at an exercise price of $2.75 per share with a five-year expiration date in a private placement.

The offering, which is expected to raise gross proceeds of about $2.1 million, is expected to close around July 22, subject to customary closing conditions.

Net proceeds from the offering will be used for working capital and general corporate purposes.

Shares of the company fell more than 30% in recent Friday premarket activity.

Price: 2.4091, Change: -1.06, Percent Change: -30.57

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment